第一单位：
Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione "G. Pascale" Napoli, Naples, Italy.
作者：
Paolo A,Ascierto [1]
;
Mario,Mandalà [2]
;
Pier Francesso,Ferrucci [3]
;
Massimo,Guidoboni [4]
;
Piotr,Rutkowski [5]
;
Virginia,Ferraresi [6]
;
Ana,Arance [7]
;
Michele,Guida [8]
;
Evaristo,Maiello [9]
;
Helen,Gogas [10]
;
Erika,Richtig [11]
;
Maria Teresa,Fierro [12]
;
Celeste,Lebbè [13]
;
Hildur,Helgadottir [14]
;
Paola,Queirolo [5]
;
Francesco,Spagnolo [15]
;
Marco,Tucci [16]
;
Michele,Del Vecchio [15]
;
Maria,Gonzales Cao [17]
;
Alessandro Marco,Minisini [18]
;
Sabino,De Placido [19]
;
Miguel F,Sanmamed [20]
;
Domenico,Mallardo [21]
;
Marcello,Curvietto [22]
;
Ignacio,Melero [1]
;
Giuseppe,Palmieri [1]
;
Antonio M,Grimaldi [22]
;
Diana,Giannarelli [23]
;
Reinhard,Dummer [1]
;
Vanna,Chiarion Sileni [24]
作者单位：
Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione "G. Pascale" Napoli, Naples, Italy.
[1]
Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy.
[2]
University of Perugia, Perugia, Italy.
[3]
Biotherapy of Tumors Unit, Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
[4]
Immunotherapy and Cell Therapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
[5]
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland.
[6]
Department of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
[7]
Department of Medical Oncology, Hospital Clínic Barcelona, Barcelona, Spain.
[8]
Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori "Giovanni Paolo II," Bari, Italy.
[9]
Oncology Unit, Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
[10]
First Department of Medicine, National and Kapodistrian University of Athens, Zografou, Greece.
[11]
Department of Dermatology, Medical University of Graz, Graz, Austria.
[12]
Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
[13]
Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden.
[14]
IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy.
[15]
Division of Melanoma Sarcoma and Rare Tumors, IRCCS European Institute of Oncology, Milan, Italy.
[16]
Department of Interdisciplinary Medicine, Oncology Unit, University of Bari "Aldo Moro," Bari, Italy.
[17]
Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[18]
Department of Medical Oncology, University Hospital Dexeus, Barcelona, Spain.
[19]
Academic Hospital "Santa Maria della Misericordia," Udine, Italy.
[20]
Department of Clinical Medicine and Surgery, University of Naples "Federico II," Naples, Italy.
[21]
Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
[22]
Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari, Unit of Cancer Genetics, IRGB-CNR, Sassari, Italy.
[23]
Medical Oncology Unit, AORN San Pio Benevento, Benevento, Italy.
[24]
Regina Elena National Cancer Institute, IRCCS-Biostatistical Unit, Rome, Italy.
[25]
Department of Dermatology, University and University Hospital Zurich, Zurich, Switzerland.
[26]
Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
[27]
DOI
10.1200/JCO.21.02961
PMID
36049147
发布时间
2023-05-28
换一批
换一批
